The risk of this second vision-threatening pathology, particularly angle closure glaucoma, may be higher than that of the general population (1.1%) in some IRD genotypes (e.g., BEST1, CRB1, MFRP) associated with microphthalmia/nanophthalmos [56]. This evidence concerns the gene BEST1 and microphthalmia.